Meeting unmet needs in ulcerative colitis

26.05.2023 | News

Meeting unmet needs in ulcerative colitis

Online healthcare professionals (eHCPs) are interested in treatment options for ulcerative colitis  and have shown excitement about emerging options. But we asked ourselves, what else do they discuss?

Using CREATION Pinpoint, we analysed 14,612 unprompted posts about ulcerative colitis written by eHCPs around the world. Imagine these eHCPs are in their hospital break room together and they start discussing their work life in ulcerative colitis, what organically comes up?

While there are some conversations about pharmaceutical treatments (583 mentions, 4% of posts) much of that is driven by responding to news (79% of treatment posts were shares / retweets).

Companies in the UC space providing treatments should be providing good data, good guidance and answering product-related questions. However, they should also show they care about the above-brand needs of their HCPs and, importantly, their patients. 

Ulcerative colitis, as such a life-altering disease, is a space where eHCPs care deeply for their patients and their daily life struggles. Three other themes emerged from eHCP which will explore: research in the area of diet and food, insurance denials and medical education.

HCPs share the latest research around diet

eHCPs love to share data with their peers on social media (30% of posts related to research, studies or data), the data discussed is not only drug-related data, or even treatment-related data in general. The conversation also covers research into risks of comorbidities and improving the diagnosis process (among other topics).

Within this active conversation about trials we saw eHCPs sharing results and their thoughts on how refined or ultra-processed foods have contributed to the global burden of chronic inflammatory diseases  such as inflammatory bowel disease in part via detrimental effects on the gut microbiota (143 eHCP mentions).

As eHCPs discuss gut microbiota and changes in the microbiome, it becomes clear there is a belief this may be a key contributing factor in the rise in IBD prevalence. eHCPs   widely shared  clinical nutrition guidelines for those working in IBD (27 eHCP shares), which included guidance on microbiota modulation.

Burden on patients of insurance denials

Many posts, especially from eHCPs in the US, expressed concern about patients being denied insurance for their ulcerative colitis treatments. Sharing these stories, HCPs vented their frustrations and made it clear they want better and easier access to medications for their patients. 

One particular story published on ProPublica sparked a lot of online conversation.  Enraged eHCPs gave evidence for care being denied to a patient, and lamented the lack of empathy shown to patients. 

Medical education

HCPs are using social media as a space to amplify opportunities for furthering medical education in ulcerative colitis. They often use the hashtag #MedEd.

Webinars hosted by the United European Gastroenterology (UEG) were designed as a place to “learn and discuss with experts in real-time”. Links to these webinars were seen in 70 eHCP posts. Posts published by a non-profit ‘IBD Horizons’ were shared more than 100 times by eHCPs as they work with a team of experts to provide free education. 

Another way eHCPs educate their peers is through their conference #IBDHorizons23 (67 eHCP mentions) which was copublished on Instagram, by Dr Anita Afzali (ibd_afzali)

 

View this post on Instagram

 

A post shared by IBDHorizons® (@ibdhorizons_)

Meet eHCPs unmet needs

Advice for a company working with HCPs in support of ulcerative colitis patients would be to continue to keep them up to speed on clinical and real world data relating to current and emerging therapies but also engage on the other issues that eHCPs are interested in. Analysis of the unprompted online conversation can reveal these issues without introducing survey bias.

In ulcerative colitis eHCPs care deeply about the burden for patients of managing their diet, and managing the cost of treating the disease.

They use digital channels to collaborate with non-profit organisations including  United European Gastroenterology and IBD Horizons, and to share learning opportunities with one another

 

Share this article

Meet the Author

Jamie Doggett

As Associate Director of Insight, Jamie leads the Analytics and Insights Team overseeing the development of insights. He works with teams to ensure the highest standards of research outputs, client delivery, and technology development.

Jamie is a country boy at heart having grown up on the sunny Isle of Wight and enjoys adventures which is reflected in a love for travel and travel literature.

Suggested next


05.01.2023 | Article

Top 50 Pharma Tracker: HCPs celebrate the Moderna and Merck combination melanoma vaccine and immunotherapy

The 5 companies mentioned the most by HCPs were Pfizer, Moderna, Johnson & Johnson....

By Francesca Gan

14.11.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

The FDA granted emergency use of Pfizer and Moderna's bivalent vaccine in children

By Francesca Gan

View all articles >